ArticleResearch square2026
Breaking the Barrier: Pro-inflammatory Stool from Infants with CHD Triggers Barrier Dysfunction within Intestinal Organoids.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Infants with congenital heart disease (CHD) undergoing cardiopulmonary bypass (CPB) frequently develop gut injury and barrier dysfunction. The effects of the post-operative gut milieu on the intestinal epithelium remain poorly defined. Given ethical challenges in obtaining intestinal tissue from these patients, organoids offer a solution to study post-CPB intestinal changes. Methods: Porcine intestinal organoids were converted from basal-out to apical-out polarity to enable luminal exposure. Organoids were treated with pre-operative and post-operative fecal supernatants derived from a neonate with CHD undergoing CPB and a non-CHD surgical control. Microbial composition and metabolite profiles were analyzed, and epithelial responses were assessed following 72-hour exposure. Results: Apical-out organoids enabled direct luminal interrogation. Post-CPB stool exhibited enriched pro-inflammatory organisms and reduced microbial diversity, increased pro-inflammatory eicosanoids, and depletion of SCFA versus control. Post-CPB fecal supernatant induced epithelial barrier dysfunction and injury with redistribution of Claudin-2 and Claudin-3, and reduced fatty acid binding protein 2. There was altered PGE2 signaling including upregulation of PGE2 synthase, downregulation of prostaglandin dehydrogenase, and altered EP2 receptor localization. Conclusion: Post-operative stool following CPB contributes to epithelial injury and maladaptive responses characterized by PGE2-axis remodeling, tight junction reorganization, and loss of mature enterocyte features. This model of CHD stool exposure in organoids provides a robust translational platform for mechanistic studies and therapeutic targeting of gut injury following CPB.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.